Technology Digest Bermuda
SEE OTHER BRANDS

Your science and technology news from Bermuda

Technology Digest Bermuda: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Bermuda.

Press releases published on July 29, 2025

Lemongrass Launches Clean Core AI Accelerator to Help SAP Customers Reduce Transformation Effort and Cost and Embrace Innovation

Lemongrass Launches Clean Core AI Accelerator to Help SAP Customers Reduce Transformation Effort and Cost and Embrace Innovation

ATLANTA, July 29, 2025 (GLOBE NEWSWIRE) -- Lemongrass, a leader in SAP consulting and transformation services, announces the launch of its Clean Core AI Accelerator, a powerful new Software-as-a-Service solution that helps SAP customers reduce technical …

Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma

Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma

SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …

Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results

Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results

BOSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

- Pioneering approach to halting the chronic neuroinflammation responsible for neurodegeneration - Trial to assess safety, PK and detect early signs of efficacy - Initial data expected in mid-2026 SACRAMENTO, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- …

GigaCloud Technology Inc. Expands Global Fulfillment Network with New Facility in Germany

GigaCloud Technology Inc. Expands Global Fulfillment Network with New Facility in Germany

EL MONTE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc. (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that one of its subsidiaries …

Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer

Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer

SYDNEY, AUSTRALIA, July 29, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an upcoming poster presentation for the …

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration

MIAMI, July 29, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced that it has completed subject enrollment in its ASCEND clinical trial evaluating VIA Disc NP for symptomatic …

AgEagle Aerial Systems Announces First Sale of Drones in Thailand

AgEagle Aerial Systems Announces First Sale of Drones in Thailand

First Sale in Southeast Asia lays foundation for manufacturer’s presence in region  WICHITA, Kan., July 29, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is proud to …

American Rebel Holdings, Inc. (NASDAQ: AREB) Ignites Second National Media Blitz with Bold New TV and Digital Ads to Increase Investor Awareness and to Target Patriotic Consumers

American Rebel Holdings, Inc. (NASDAQ: AREB) Ignites Second National Media Blitz with Bold New TV and Digital Ads to Increase Investor Awareness and to Target Patriotic Consumers

Capitalizing on Strong April 2025 Campaign Response, American Rebel Accelerates Outreach with Fresh Messaging to Maximize Impact. Campaign Designed to Drive New Shareholder Interest Through High-Visibility Media Activation and Nationwide Reach 30-Second …

ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference

ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference

Presentation to highlight the Company’s proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310 Posters highlighting PRECISE-AD, the Company’s Phase 1b clinical trial design and optimization of biomarkers in AD Progress with trial …

FluidCloud Emerges from Stealth with $8.1 Million to Unlock the Cloud

FluidCloud Emerges from Stealth with $8.1 Million to Unlock the Cloud

PLEASANTON, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- FluidCloud, the pioneer in portable cloud infrastructure, launched today with $8.1 million in seed funding led by Unusual Ventures with participation from U First Capital. FluidCloud is introducing the …

Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease

Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease

- Zervimesine’s impact on debilitating DLB behavioral symptoms highlighted in podium presentation - - Plasma p-tau217 levels can identify Alzheimer’s patients most likely to benefit from zervimesine treatment - - Plasma and CSF biomarkers support …

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q2 2025 net product revenue of $156.8 million, representing 52% year-over-year growth – – ARCALYST 2025 expected net product revenue increased to $625 - $640 million – – KPL-387 Phase 2/3 clinical trial in recurrent pericarditis …

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on …

Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Revenue of $182 million, year-over-year increase of 15% as reported and 17% organic non-COVID growth Orders grew sequentially and greater than 20% year-over-year Increasing revenue guidance to range of $715 to $735 million, which represents 12.5% -15.5% …

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

~ Achieved alignment with the FDA on the AMT-130 statistical analysis plan and CMC requirements to support a planned BLA submission in the first quarter of 2026; ~ Company expects to present AMT-130 topline three-year data in September 2025 ~ ~ Presented …

WAIC 2025: GPTBots Multi-Agent Platform Turns AI Tools into Collaborative Teams

WAIC 2025: GPTBots Multi-Agent Platform Turns AI Tools into Collaborative Teams

HONG KONG, July 29, 2025 (GLOBE NEWSWIRE) -- The highly anticipated 2025 World Artificial Intelligence Conference (WAIC) is underway in Shanghai, bringing together global leaders in AI innovation. GPTBots.ai, a leading enterprise-grade AI agent building …

Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025

Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025

PITTSBURGH, July 29, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second quarter 2025 financial results on Monday, August 4, 2025, prior to …

Energous Wireless Power Solutions Reports Second Quarter 2025 Results

Energous Wireless Power Solutions Reports Second Quarter 2025 Results

- Reports Revenue of $1 Million - Highest Quarterly Revenue Since 2016 - - Accounts for Lowest Quarterly Net Loss in the last Decade - - Announces $4 million Order Backlog - SAN JOSE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Energous Corporation d/b/a …

EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

– LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong enthusiasm for the DURAVYU pivotal program across the global retinal community – – Over 800 patients enrolled across the LUGANO and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions